Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Februar 2026 14:11 ET | Quelle: Robbins LLP

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
18. Februar 2026 14:07 ET | Quelle: Robbins LLP

Stockholders Who Lost Money Investing in Ultragenyx Pharmaceutical Inc. Should Contact Robbins LLP for Information About Recovering Their Losses from RARE

Robbins LLP is Investigating Allegations that Ultragenyx Pharmaceutical Inc. (RARE) Misled Investors Regarding Phase III Orbit and Cosmic Studies
18. Februar 2026 14:03 ET | Quelle: Robbins LLP

Ramaco Resources, Inc. Shareholders Who Lost Money Investing in METC Should Contact Robbins LLP for Information About Recovering Their Losses

Robbins LLP is Investigating Allegations that Ramaco Resources, Inc. (METC) Overstated Development Progress at the Company's Brook Mine
18. Februar 2026 13:44 ET | Quelle: Robbins LLP

Stockholders Who Lost Money Investing in Oracle Corporation Should Contact Robbins LLP for Information About Recovering Their Losses from ORCL

Robbins LLP is Investigating Allegations that Oracle Corporation (ORCL) Misled Investors Regarding its Data Center Capabilities for AI Infrastructure
18. Februar 2026 13:12 ET | Quelle: Robbins LLP

Stockholders Who Lost Money Investing in BlackRock TCP Capital Corp. Should Contact Robbins LLP for Information About Recovering Their Losses from TCPC

Robbins LLP is Investigating Allegations that BlackRock TCP Capital Corp. (TCPC) Misled Investors Regarding its Business Prospects
17. Februar 2026 14:29 ET | Quelle: Robbins LLP

Robbins LLP Urges AGL Stockholders with Large Losses to Contact the Firm for Information About Leading the Agilon Health, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects
16. Februar 2026 20:24 ET | Quelle: Robbins LLP

KD Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Kyndryl Holdings, Inc. Class Action

Robbins LLP is Investigating Allegations that Kyndryl Holdings, Inc. (KD) Materially Misstated its Financial Statements
16. Februar 2026 19:42 ET | Quelle: Robbins LLP

QURE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the uniQure N.V. Class Action

The Allegations: Robbins LLP is Investigating Allegations that uniQure (QURE) Misled Investors Regarding the Likelihood of FDA Approval of its Drug.
13. Februar 2026 14:57 ET | Quelle: Robbins LLP

DOOR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Masonite International Corporation Class Action

Robbins LLP is Investigating Allegations that Masonite International Corporation (DOOR) Misled Investors Regarding its Acquisition by Owens Corning's Doors
13. Februar 2026 14:56 ET | Quelle: Robbins LLP

INO Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Class Action

Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device

Nächste Seite